THERALASE Aktie

>THERALASE Performance

1 Woche: -5,8%

1 Monat: -2,4%

3 Monate: +83,0%

6 Monate: +54,8%

1 Jahr: +43,8%

laufendes Jahr: +83,0%

>THERALASE Aktie

Name:

THERALASE TECHNOLOGIE.INC

Land:

Kanada

Sektor:

Gesundheit

ISIN/ Wkn:

CA88337V1004 / A0DLB7

Symbol/ Ticker:

TTX (Frankfurt)

Kürzel:

FRA:TTX, ETR:TTX, TTX:GR

Index:

Webseite:

https://theralase.com/

Profil:

Theralase Technologies Inc. is a prominent player in the medical technology sector, focusing on the design, manufacture, and commercialization of innovative laser technologies. The company's primary purpose is to develop advanced laser systems for th..
>Volltext..

Marktkapitalisierung:

44.8 Mio. EUR

Unternehmenswert:

44.95 Mio. EUR

Umsatz:

0.62 Mio. EUR

EBITDA:

-2.58 Mio. EUR

Nettogewinn:

-2.71 Mio. EUR

Gewinn je Aktie:

-0.01 EUR

Schulden:

0.2 Mio. EUR

Liquide Mittel:

0.05 Mio. EUR

Operativer Cashflow:

-1.56 Mio. EUR

Bargeldquote:

0.05

Umsatzwachstum:

-6.47%

Gewinnwachstum:

7.3%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

THERALASE

Letzte Datenerhebung:

05.04.26

>THERALASE Kennzahlen

Aktien/ Unternehmen:

Aktien: 257.06 Mio. St.

Frei handelbar: 92.75%

Leerverk. Aktien: -

Rückkaufquote: -3.33%

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 135.41%

Bewertung:

KGV: -

KGV lG: -

KUV: 71.96

KBV: 73.06

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: 31.46%

Gewinnmarge: -434.88%

Operative Marge: -440.39%

Managementeffizenz:

Gesamtkaprendite: -139.83%

Eigenkaprendite: -269.41%

>THERALASE Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung, Medizinprodukte & -technik/ Implantate/ Wundpflege

>THERALASE Chart & Kurs - Stuttgart

>THERALASE News

10.03.26 - 12:06	Theralase Technologies Inc.: Theralase(R) Closes $1.1 M Non-Brokered Private Placement (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - March 10, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to th......

09.03.26 - 12:30	Theralase Technologies Inc.: Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - March 9, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to the......

20.02.26 - 14:06	Theralase Technologies Inc.: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - February 20, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to ......

20.02.26 - 13:12	Theralase Technologies Inc.: Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress (Newsfile)
	This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the past.Toronto, Ontario--(Newsfile Corp. - February 20, 2026) - Theralase Tech......

17.02.26 - 13:12	Theralase Technologies Inc.: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - February 17, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to......

10.02.26 - 13:12	Theralase Technologies Inc.: Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to......

04.02.26 - 13:12	Theralase Technologies Inc.: Theralase(R) Provides Update on Bladder Cancer Clinical Study (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - February 4, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to ......

12.01.26 - 18:27	XFRA: TTX: Wiederaufnahme/Resumption (XETRA)
	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN THERALASE TECHNOLOGIE.INC TTX CA88337V1004 AB/FROM ONWARDS 12.01.2026 18:16 CET...

12.01.26 - 13:06	Theralase Technologies Inc.: Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer (Newsfile)
	The collaborative clinical study will evaluate ADSTILADRIN (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar (TLD-1433) in patients with Bacillus Calmette-Guérin......

12.01.26 - 08:03	XFRA: TTX: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL THERALASE TECHNOLOGIE.INC TTX CA88337V1004 BAW/UFN...

12.01.26 - 08:01	XFRA: INSTRUMENT_SUSPENSION - CA88337V1004 (XETRA)
	Instrument ID [2982] (TTX - CA88337V1004) suspended...

23.12.25 - 23:00	Theralase(R) closes $1.3M non-brokered private placement (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.12.25 - 22:54	Theralase Technologies Inc.: Theralase(R) Closes $1.3 M Non-Brokered Private Placement (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company pioneering l......

12.12.25 - 23:15	Theralase commences C$ 2M non-brokered private placement (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.12.25 - 23:06	Theralase Technologies Inc.: Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company pioneering l......

24.11.25 - 13:06	Theralase Technologies Inc.: Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company pioneering l......

17.11.25 - 13:06	Theralase Technologies Inc.: Theralase(R) Investor Conference Call Reminder (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, ......

10.11.25 - 13:06	Theralase Technologies Inc.: Theralase(R) Releases 3Q2025 Financial Statements (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, ra......

03.11.25 - 13:12	Theralase Technologies Inc.: Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering ......

24.09.25 - 13:06	Theralase Technologies Inc.: Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus (Newsfile)
	Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneerin......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram